Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Eli Lilly and NYSE:LLY |
823,03 B | 23,56% | 6/6 | 34,75% | 16,14% | 36,99% | DOWN |
|
AstraZeneca PLC LSE:AZN |
227,84 B | 8,90% | 5/6 | 11,21% | -29,05% | 16,38% | UP |
|
Merck NYSE:MRK |
297,40 B | 7,67% | 6/6 | -21,36% | -10,44% | 9,73% | UP |
|
Pfizer NYSE:PFE |
159,73 B | 7,82% | 4/6 | -5,31% | 18,85% | -3,85% | UP |
|
Sanofi ENXTPA:SAN |
99,89 B | 5,21% | 5/6 | 7,19% | 13,59% | 20,89% | DOWN |
|
argenx ENXTBR:ARGX |
38,53 B | 81,61% | 5/6 | 40,51% | 39,84% | 40,14% | DOWN |
|
Teva Pharmaceutical Industries NYSE:TEVA |
35,08 B | 1,20% | 4/6 | -6,42% | -141,58% | 26,16% | UP |
|
Genmab A/S CPSE:GMAB |
105,16 B | 14,29% | 4/6 | -4,48% | 54,09% | 37,19% | DOWN |
|
Viatris NasdaqGS:VTRS |
15,56 B | -3,69% | 4/6 | 2,85% | -37,08% | 25,83% | UP |
|
Recordati Industria Chimica e Farmaceutica S.p.A. BIT:REC |
10,03 B | 10,99% | 5/6 | 4,50% | 21,38% | 17,25% | DOWN |
|
Orion Oyj HLSE:ORNBV |
9,80 B | 15,01% | 5/6 | 5,49% | 5,03% | 7,60% | UP |
|
ALK-Abelló A/S CPSE:ALK B |
44,80 B | 32,62% | 5/6 | 55,34% | 25,38% | 26,11% | UP |
|
Alkermes NasdaqGS:ALKS |
5,88 B | 18,29% | 5/6 | 17,01% | 14,18% | 21,50% | DOWN |
|
Hikma Pharmaceuticals PLC LSE:HIK |
2,73 B | 0,95% | 4/6 | 2,16% | 30,23% | 50,28% | DOWN |
|
Zealand Pharma A/S CPSE:ZEAL |
20,83 B | 71,10% | 4/6 | -51,93% | 89,82% | 69,49% | DOWN |
|
Almirall BME:ALM |
2,61 B | -7,92% | 3/6 | 34,41% | 0,40% | 18,01% | UP |
|
Pharma Mar BME:PHM |
1,52 B | 48,61% | 6/6 | -25,40% | 5,39% | 21,85% | UP |
|
Cosmo Pharmaceuticals N.V. SWX:COPN |
1,34 B | 12,72% | 4/6 | 174,36% | -92,83% | 53,94% | DOWN |
|
Faes Farma BME:FAE |
1,45 B | 5,71% | 3/6 | 17,85% | -14,16% | 15,45% | UP |
|
DBV Technologies ENXTPA:DBV |
1,01 B | -30,81% | 3/5 | 32,19% | -270,88% | 37,74% | UP |
